Search

everythinglearnresearchcommunity

for

Search:↓

Insulin resistance might not be enough to worsen blood vessel function in young, nonobese women with polycystic ovary syndrome.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Menopause affects hair and skin; more research needed for treatment.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

The spiny mouse is a unique menstruating rodent that can help us understand menstruation and reproductive disorders.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Using anabolic-androgenic steroids can harm men's reproductive health and increase the risk of heart problems and death.

High Nesfatin-1 and low Vitamin D may increase blood pressure and heart rate in women with PCOS.

Managing oxidative stress might help treat low testosterone and related chronic diseases in aging men.

The cat's hypothyroidism was successfully managed with levothyroxine, leading to a stable condition.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

Blood AMH levels are higher in women with PCOS than in those with other similar conditions.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.

Menstrual abnormalities in PCOS women may not greatly affect their metabolic and hormonal profile.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

PCOS is a common hormonal disorder in women, often involving menstrual issues and increased diabetes risk, managed through lifestyle changes and targeted treatments.

Canrenone effectively reduced hair growth and testosterone levels in women with excessive hairiness.

Vitamin D deficiency is linked to a higher chance of metabolic syndrome in women with PCOS.

Sons of mothers with polycystic ovary syndrome (PCOS) have a higher risk of obesity and insulin resistance, possibly due to certain genes and factors passed down from their mothers.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

The 39th Manfred Donike Workshop discussed methods for detecting misuse of steroids, gene doping, and the complexity of identifying drug residues in urine, highlighting the ongoing efforts to improve global anti-doping work.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

The Free Androgen Index (FAI) is the best indicator of early hair loss in men before age 30.

Curcuma aeruginosa Roxb. may help treat hair loss by affecting specific biological pathways.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

Abuse of anabolic steroids in Iraqi athletes leads to negative effects on hormones, liver and kidney function, blood sugar, and cholesterol levels.